💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Alkermes plc (ALKS)
« Back to company indexALKS Chatter Timeline
Stock Ticker for ALKS
Most Active Tweeters for ALKS
| User | Tweets |
|---|---|
| @FlashAlert_me | 7 |
| @mediasentiment | 7 |
| @Tickeron | 6 |
| @sbwcws | 4 |
| @usasingh1 | 4 |
Recent Tweets for ALKS
 |
@InsiderForms $ALKS Insider MCKEON BRIAN P has Purchased 10,000 Shares. Title :Director Total Cost: $264,269.0 Buy/Sell : Buy T… https://t.co/Z3AxWbFM8P August 4th 2021, 9:08pm |
 |
@RajputMoksh $ALKS may stall here for a bit as the price hits the 200 EMA & previous resistance point. https://t.co/cdCx1Z0djq August 4th 2021, 4:08pm |
 |
@kwhenfinance Alkermes plc Shares Climb 100.0% Past Previous 52-Week High - Market Mover https://t.co/0Otl12EbW0 $ALKS #stockmarket #kwhenfinance August 4th 2021, 3:08pm |
 |
@usasingh1 $ALKS addiction #AlexanderDenner https://t.co/iacLw5Rx3r August 4th 2021, 2:08pm |
 |
@t_rup_ RT @EdenRahim: In a #biotech bloodbath its nice to see an actual non-mRNA vaccine bio, $ALKS grind up against gale force winds to that elus… August 4th 2021, 1:08pm |
 |
@EdenRahim In a #biotech bloodbath its nice to see an actual non-mRNA vaccine bio, $ALKS grind up against gale force winds to that elusive 52-week high August 4th 2021, 1:08pm |
|
@usasingh1 $ALKS holding all these in Roth IRA @leonardi1452 Alexander Denner Zindabad . https://t.co/UNVejL9gti August 3rd 2021, 10:08pm |
 |
@PMDiChristina We’ve been here all the way, time to ring $ALKS https://t.co/fHVHnA3NkJ August 3rd 2021, 9:08pm |
 |
@weeklystockchar $ALKS 130m. Busted thru top of BF. If you look at intraday chart from y'day - very steady accumulation (buy program… https://t.co/t7bNIBuNMd August 3rd 2021, 5:08pm |
 |
@Gambiste1 RT @billgunderson: Good news for $ALKS on their melanoma treatment. The stock is breaking out. No. 566 rank overall. https://t.co/yY2aReZn2U August 3rd 2021, 4:08pm |
 |
@billgunderson Good news for $ALKS on their melanoma treatment. The stock is breaking out. No. 566 rank overall. https://t.co/yY2aReZn2U August 3rd 2021, 3:08pm |
 |
@OliveDrabGreen Reply about highest conviction long, $ALKS, aging like fine wine. https://t.co/Bpgdn7XRr4 August 3rd 2021, 3:08pm |
 |
@pivotinvestor $ALKS started off August with a bang. R2 key level. https://t.co/t8JfZsDguG August 3rd 2021, 12:08pm |
 |
@sbwcws Alkermes shares have additional upside, says Mizuho $ALKS August 3rd 2021, 11:08am |
 |
@1stOncology #Alkermes Receives #FDA #FastTrackDesignation for #NemvaleukinAlfa for the Treatment of #MucosalMelanoma $ALKS https://t.co/yzayhoQFHC August 3rd 2021, 8:08am |
 |
@newsfilterio Alkermes Receives FDA Fast Track Status For Mucosal Melanoma Immunotherapy $ALKS https://t.co/sDUqcIcmKR August 3rd 2021, 8:08am |
 |
@art_isit $ALKS -The FDA has granted Fast Track designation to Alkermes plc's (NASDAQ: ALKS) nemvaleukin alfa (nemvaleukin) f… https://t.co/7kogAUgz1y August 3rd 2021, 5:08am |
|
@PMDiChristina Very strong $ALKS https://t.co/d0RP7oY4Qn August 3rd 2021, 3:08am |
 |
@Tickeron $ALKS's Aroon indicator reaches into Uptrend on July 14, 2021. View odds for this and other indicators:… https://t.co/itbqgbDvlX August 3rd 2021, 2:08am |
 |
@the_chart_life $ALKS Alkermes ... https://t.co/uzD6YNHRCh August 3rd 2021, 1:08am |
 |
@IOInvestors Alkermes plc $ALKS Stock Is Higher After Receiving Fast Track Designation for Melanoma Treatment https://t.co/DYTgbcpZim August 2nd 2021, 4:08pm |
 |
@ShortAlgoTrades $ALKS Waiting for short signal on ALKS https://t.co/Li97gmGrIT August 2nd 2021, 2:08pm |
 |
@ShortAlgoKing $ALKS Waiting for short signal on ALKS https://t.co/TsaicsYyxi August 2nd 2021, 2:08pm |
 |
@StckPro $ALKS NEW ARTICLE : Alkermes Receives FDA Fast Track Status For Mucosal Melanoma Immunotherapy… https://t.co/ts2Qk3oInz August 2nd 2021, 2:08pm |
 |
@Briefingcom $ALKS: Alkermes: FDA granted Fast Track designation to nemvaleukin alfa (nemvaleukin) for the treatment of mucosal.… https://t.co/wEWAY7RCmn August 2nd 2021, 1:08pm |
|
@sbwcws Alkermes receives FDA Fast Track designation for nemvaleukin alfa $ALKS August 2nd 2021, 12:08pm |
 |
@wboscoho Has $ALKS finally hit the stride? FDA FastTracks its nemvaleukin against mucosal melanoma https://t.co/S41446sQOi August 2nd 2021, 12:08pm |
 |
@OpenOutcrier $ALKS (+1.3% pre) Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Me… https://t.co/RC92TuKYyI August 2nd 2021, 11:08am |
 |
@ethanFlare $ALKS - Alkermes melanoma treatment nemvaleukin gets FDA Fast Track status Cap size: mid, Float 91.9%, Short Intere… https://t.co/ija93SWrej August 2nd 2021, 11:08am |
 |
@MarketCurrents $ALKS - Alkermes melanoma treatment nemvaleukin gets FDA Fast Track status https://t.co/19AL7R7DSD August 2nd 2021, 11:08am |
 |
@FlashAlert_me $ALKS [15s. delayed]: Issued Press Release on August 02, 07:00:00: Alkermes Receives FDA Fast Track Designation for… https://t.co/gGmLuQKbY0 August 2nd 2021, 11:08am |
 |
@biostockinfo RT @BioStocks: $ALKS Receives Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma August 2nd 2021, 11:08am |
 |
@BioStocks $ALKS Receives Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma August 2nd 2021, 11:08am |
 |
@StockNewsBot2 $ALKS Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma https://t.co/8VRtf2hwfe August 2nd 2021, 11:08am |
 |
@TrueTraderNet $ALKS Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma - Source https://t.co/XR9MAJHQ9O August 2nd 2021, 11:08am |
 |
@stock_titan $ALKS Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma https://t.co/NFZq3DJSZw August 2nd 2021, 11:08am |
 |
@quantisnow $ALKS ? Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma… https://t.co/JcE5TqKjnq August 2nd 2021, 11:08am |
|
@Tickeron $ALKS's Aroon indicator reaches into Uptrend on July 14, 2021. View odds for this and other indicators:… https://t.co/JtlFZnH13T August 1st 2021, 7:08pm |
|
@usasingh1 $ALKS Roth IRA portfolio @HedgeMind https://t.co/2OVpO4v1cb August 1st 2021, 3:08am |
|
@kwhenfinance Alkermes plc Shares Near 52-Week High - Market Mover https://t.co/9RLEnWDa0z $ALKS #stockmarket #kwhenfinance August 1st 2021, 1:08am |
 |
@mediasentiment $ALKS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 84 July 31st 2021, 8:07am |
|
@mediasentiment $ALKS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 83 July 31st 2021, 8:07am |
 |
@day_trading_de ALKS (Alkermes plc.) ? #Insider #stock alert! ? #Sale on 2021-07-29 - $ALKS ??: Gaffin David Joseph (SVP, CLO, Alke… https://t.co/iMVDeJ7lmZ July 30th 2021, 8:07pm |
 |
@fintel_io Insider David Joseph Gaffin reports selling 14,000 shares of $ALKS for a total cost of $364,000.00 https://t.co/8qrZ8PlXU9 July 30th 2021, 8:07pm |
|
@FlashAlert_me $ALKS [15s. delayed] filed SEC form 4: Insider Gaffin David Joseph: Disposed 14,000 of Ordinary Shares at price $2… https://t.co/TCiaT53TRd July 30th 2021, 8:07pm |
 |
@formwhisperscom #FWSells $ALKS Gaffin David Joseph, SVP, CLO, Alkermes, Inc. of Alkermes plc. sold 14,000 shares on 2021-07-29. https://t.co/U2aerG4v2s July 30th 2021, 8:07pm |
|
@mediasentiment $ALKS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 1241 July 29th 2021, 6:07pm |
|
@mediasentiment $ALKS new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 1174 July 29th 2021, 4:07pm |
 |
@Jarvis_Alerts $ALKS [Alkermes]: Mizuho Maintains Buy Raises Price Target $29 --> 33 charts: courtesy of finviz https://t.co/zb5tRXpPhE July 29th 2021, 3:07pm |
 |
@tgn1162 RT @felix61165477: @the_chart_life $ALKS ?? https://t.co/Ezk6TEelTs July 29th 2021, 2:07pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?